LRRK2 and Parkinson disease: No differences in age (F = 1.505; P = 0.226), Montreal Cognitive Assessment (MoCA) (F = 0.805; P = 0.449), Movement Disorders Society Unified Parkinson’s Disease Rating Scale (MDS UPDRS)-III score (F = 1.138; P = 0.324), or education (F = 2.270; P = 0.107) were observed between LRRK2 NMCs, GBA1 NMCs, and the control group without genetic mutations.